Higher myocarditis risk after COVID-19 than mRNA vaccination; contrary to Peter McCullough’s claim, young persons decrease their risk by getting vaccinated

Myocarditis, an inflammation in the heart muscle, is typically caused by viral infections. In rare instances, myocarditis can also occur after COVID-19 vaccination. During the global COVID-19 vaccination campaign, the mRNA vaccines have been linked to rare cases of post-vaccine myocarditis that are usually mild and resolve; these have occurred primarily in young males. On the other hand, COVID-19 itself carries a much higher risk of heart complications, including myocarditis. Moreover, the COVID-19 vaccines decrease the risk of COVID-19-related myocarditis, meaning that COVID-19 vaccination continues to be recommended to young persons.

Contrary to Peter McCullough’s claim, getting vaccinated is safer than getting COVID-19, in spite of rare cases of myocarditis

Although cases of myocarditis have been reported following mRNA vaccination against COVID-19, the cases are rare, usually mild and patients rapidly recover. In contrast, COVID-19 is associated with a higher rate of myocarditis with potential risks of clinical complications. Overall, based on all scientific evidence available, the benefits of vaccines largely outweigh their risks.

Joe Rogan interview with Peter McCullough contains multiple false and unsubstantiated claims about the COVID-19 pandemic and vaccines

To date, more than 241 million people in the U.S. have received at least one dose of COVID-19 vaccine. Clinical trials as well as the safety monitoring of COVID-19 vaccination campaigns provide overwhelming evidence that the vaccines’ benefits far outweigh their risks. There’s no evidence indicating that the amount of spike protein generated by mRNA vaccination is dangerous. The use of multiple doses of COVID-19 vaccines isn’t unusual or unprecedented; some childhood vaccines that have been used for decades also require four or more doses for complete immunization.

Vaccines are a safer alternative for acquiring immunity compared to natural infection and COVID-19 survivors benefit from getting vaccinated, contrary to claims by Peter McCullough

Clinical trials showed that COVID-19 vaccines are effective against the disease and have an excellent safety profile. While infection can also confer protective immunity, this also comes with the risks associated with disease, such as death and health complications. Vaccination develops immunity without running these risks, making vaccines the safer choice. COVID-19 survivors also benefit from vaccination. For example, vaccination may help prevent reinfection in survivors who don’t develop protective immunity from infection alone, while vaccine boosters can help build immunity to virus variants.

Study led by FDA researchers didn’t find that the Pfizer-BioNTech COVID-19 vaccine caused blood clots, contrary to viral claims on social media

Certain COVID-19 vaccines, specifically the viral vector vaccines like the AstraZeneca and J & J vaccines, are associated with an increased risk of a blood clotting disorder called vaccine-induced thrombotic thrombocytopenia, which can be fatal. At the moment, there isn’t evidence indicating that mRNA COVID-19 vaccines are associated with the same risk. However, it’s important to also consider that getting COVID-19 itself increases a person’s risk of developing blood clotting problems to a greater extent than the viral vector COVID-19 vaccines.

Medical exemptions to COVID-19 vaccines are granted for contraindications, not including history of blood clots or adverse reaction to prior vaccine

COVID-19 vaccines are safe and effective against severe illness and death. People who have contraindications to COVID-19 vaccines can get a medical exemption. However, an adverse reaction to a previous vaccine and a history of blood clots aren’t, on their own, reasons not to vaccinate. On the contrary, COVID-19 vaccines are recommended for people with a history of blood clots, as they are at a higher risk of severe COVID-19 and related complications, including blood clotting.

Comparing SARS-CoV-2 infection rate of vaccinated and unvaccinated populations doesn’t reflect the real COVID-19 vaccine effectiveness

Vaccinated and unvaccinated populations may differ in many characteristics, such as age, population size, social behavior or health seeking behavior. These differences must be taken into consideration when comparing the SARS-CoV-2 infection rates between vaccinated and unvaccinated populations. Failure to do so may lead to biased conclusions. Studies accounting for these differences showed that COVID-19 vaccines effectively reduce the risk of getting sick.